A compliance officer investigating a referral arrangement that violates the Anti-Kickback Statute faces exposure well beyond the statute itself. Since March 23, 2010, 42 U.S.C. § 1320a-7b(g) has provided that a claim for items or services resulting from an AKS violation is, by operation of law, a false or fraudulent claim under the False Claims Act. That single sentence converts a kickback question into a False Claims Act damages calculation, with treble damages and per-claim penalties applied across every claim the kickback touched, not just the kickback transaction itself.
The 2010 ACA Amendment to the Anti-Kickback Statute
Before 2010, the government had to prove that a provider who violated the Anti-Kickback Statute also submitted a claim containing a false certification of program compliance, an extra step that gave defendants room to argue the two statutes were separate. Section 6402(f) of the Patient Protection and Affordable Care Act, Pub. L. 111-148, closed that gap by adding subsection (g), which states that a claim including items or services resulting from an AKS violation constitutes a false or fraudulent claim under the False Claims Act, 31 U.S.C. §§ 3729-3733. The amendment also removed any requirement that the defendant have actual knowledge of the Anti-Kickback Statute or specific intent to violate it. A referral arrangement that violates the AKS is now, on its own, sufficient to plead falsity under the FCA.
The Tainted Claim Theory
The government's litigating position, often called the tainted claim theory, treats every claim connected to the kickback as false, not only the specific service the kickback induced. A single illegal referral arrangement can taint every claim submitted downstream of it, across every payor and every date of service. Courts disagree on how directly the kickback must cause the claim: some circuits require only a causal connection between the kickback and the referral, while others require proof the claim would not have been submitted but for the kickback. Either standard, once met, reaches the full volume of downstream claims, not a single transaction. Many of these cases begin as qui tam actions filed under seal by an employee, competitor, or business partner with direct knowledge of the arrangement.
The Damages Multiplier
The tainted claim theory establishes falsity. The FCA's damages structure then multiplies the exposure: every claim found to result from the kickback carries treble damages, three times the government's loss, plus a per-claim civil penalty currently between $14,308 and $28,619, adjusted annually for inflation. A kickback arrangement that ran for two years and touched thousands of claims can turn a six-figure kickback into eight- or nine-figure exposure once the multiplier applies claim by claim. Our companion piece on False Claims Act Damages and Per-Claim Penalties works through how the per-claim penalty stacks against claim volume.
Resolution of an AKS-based False Claims Act matter frequently adds a corporate integrity agreement and raises the risk of an OIG exclusion, either of which can end a provider's ability to bill federal healthcare programs. Our companion piece on Corporate Integrity Agreements: Terms, Costs, and Negotiation works through how those terms get negotiated once a settlement is on the table. A parallel criminal referral is also possible when the underlying conduct is willful; see FCA Civil Exposure vs Criminal Charges: Keeping Them Apart for how the two tracks diverge.
A kickback that costs a few thousand dollars can taint a claim volume worth tens of millions once treble damages and per-claim penalties apply.
Why Early Legal Counsel Is Critical
It is critical that healthcare companies and compliance officers promptly retain experienced healthcare defense counsel upon learning of a referral arrangement that may implicate the Anti-Kickback Statute, or upon receiving a subpoena or civil investigative demand tied to a kickback allegation. Early legal intervention can protect the company's rights, scope the actual volume of claims at risk before the government does, avoid inadvertent admissions, and preserve defenses to the causation element the tainted claim theory depends on. Delaying legal representation can significantly affect the outcome of a matter.
How Health Law Alliance Can Help
Health Law Alliance defends healthcare companies and providers against False Claims Act exposure built on Anti-Kickback Statute allegations, from the initial internal investigation through qui tam litigation and government-initiated actions. Our bench includes a former federal prosecutor and a former senior healthcare compliance executive, background that shapes how we evaluate causation and claim volume before the government finalizes its damages theory. If your organization is facing an AKS-based False Claims Act inquiry, contact us for a free, confidential consultation.
